Zydus’ Virafin gets emergency use approval from DGCI


On Friday, Zydus Cadila declared that the Drug Controller General of India (DCGI) had approved the emergency use of its drug ‘Virafin' for treating moderate cases of COVID-19 in adults.

A release by Cadila Health said, “The drug has also shown efficacy against other viral infections.”

Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: “The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19.”